Trial intelligence / Profile preview

Anakinra for refractory articular manifestations in systemic lupus erythematosus

2011-005392-16Phase 2Completed

Sponsor
Dr Josep Ordi Ros
Start
Apr 2012
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of anakinra in systemic lupus erythematosus (SLE), sponsored by Dr Josep Ordi Ros. Started Apr 2012; status: completed.

02

Drugs

anakinra
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on 2011-005392-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005392-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call